|
hormone-replacement trials halted
by Angela Spivey
NC-Chapel
Hill is one of 40 research centers that recently halted a trial of hormone-replacement
therapy (HRT) in healthy postmenopausal women after preliminary results showed
the risks outweighed the benefits. Five years of data collection from more than
16,000 women who had not had hysterectomies showed that the treatment slightly
increased the risk of breast cancer and provided no benefit in preventing heart
attacks and strokes.
The results contradict the belief that taking HRT for long periods is beneficial
for all postmenopausal women. "The bottom line is that estrogen plus progestin
is not a viable option to prevent chronic disease," says Gerardo Heiss, professor
of epidemiology. These results do not address, however, the effectiveness or safety
of this particular combination of hormones (or other combinations) when used for
short periods of time to treat symptoms of menopause such as hot flashes and vaginal
dryness. Heiss says that women should talk to their doctors to determine whether
they should continue with HRT, especially if they've been on it for more than
two years.
A second trial of estrogen alone in 11,000 women who have had hysterectomies
continues unchanged. Both trials are part of a larger study known as the Women's
Health Initiative.
Heiss is a member of the Women's Health Initiative Steering Committee. Other
Carolina researchers involved are Ellen Wells, assistant professor of obstetrics
and gynecology, David Ontjes, professor of medicine, Carla Sueta, associate professor
of medicine, Kathy Light, professor of psychiatry, Pamela Haines, associate professor
of nutrition, Etta Pisano, associate professor of radiology, and Barbara Hulka,
professor emeritus of epidemiology.
The National Heart, Lung, and Blood Institute sponsors
the Women's Health Initiative. A paper describing the findings in detail appeared
in the July 17 issue of the Journal of the American Medical Association.
Angela Spivey is the associate editor of Endeavors magazine.
[Email
Angela Spivey. >Get
full contact info for Angela Spivey.]
|